ENOV | Enovis CorporationNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$20.89
+$0.27 (+1.31%)

Enovis Corporation (ENOV) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.

The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is below both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $20.89 vs 50 $19.81 / 200 $23.04
Projection
No cross projected
Test
No active test
Last cross
Death cross 25 Sep 2026 ยท projected 20 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $19.91 vs 50 $23.80 / 200 $41.40
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 16:00 ET

Price
between the two $20.89 vs 50 $19.65 / 200 $22.53
Projection
No cross projected
Test
No active test
Last cross
Golden cross 23 Jul 2026 ยท projected 26 bars out

Cross history

20
crosses on record since 2023
10 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
25 Sep 2026Death steepdaily20 bars outNot tested
21 Aug 2026Golden flatdaily29 bars out4 bar cross test
23 Jul 2026Golden4-hour26 bars outNot tested
17 Jun 2026Death4-hour18 bars outNot tested
7 May 2026Golden4-hour14 bars out1 bar cross test

About ENOV

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$26.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.